Literature DB >> 18165373

Managing cancer pain with nonpharmacologic and complementary therapies.

Lynette A Menefee Pujol1, Daniel A Monti.   

Abstract

Nonpharmacologic interventions are important adjuncts to treatment modalities for patients with cancer pain. A variety can be used to reduce pain and concomitant mood disturbance and increase quality of life. Physicians may feel relatively uninformed about which modalities have been used for patients with cancer and have scientific support. This article reviews several nonpharmacologic and complementary and alternative modalities commonly used by patients with cancer pain. It focuses on those having empirical support or promising preliminary evidence, with the goal of familiarizing physicians with therapies that may complement regular oncologic care. This review updates an article published in November 2005. An anecdotal case study has been added to illustrate incorporation of nonpharmacologic and complementary therapies in the treatment of a patient with cancer-related pain.

Entities:  

Mesh:

Year:  2007        PMID: 18165373

Source DB:  PubMed          Journal:  J Am Osteopath Assoc        ISSN: 0098-6151


  10 in total

Review 1.  Integrative oncology: managing cancer pain with complementary and alternative therapies.

Authors:  Alice Running; Teresa Seright
Journal:  Curr Pain Headache Rep       Date:  2012-08

2.  Mindfulness-Based Stress Reduction in Breast Cancer Survivors with Chronic Neuropathic Pain: A Randomized Controlled Trial.

Authors:  Yaadwinder Shergill; Danielle B Rice; Eve-Ling Khoo; Virginia Jarvis; Tinghua Zhang; Monica Taljaard; Keith G Wilson; Heather Romanow; Brittany Glynn; Rebecca Small; Joshua A Rash; Andra Smith; Lynette Monteiro; Catherine Smyth; Patricia A Poulin
Journal:  Pain Res Manag       Date:  2022-07-07       Impact factor: 2.667

3.  Mindfulness-based stress reduction: a non-pharmacological approach for chronic illnesses.

Authors:  Asfandyar Khan Niazi; Shaharyar Khan Niazi
Journal:  N Am J Med Sci       Date:  2011-01

4.  Complementary Therapies for Symptom Management in Cancer Patients.

Authors:  Aanchal Satija; Sushma Bhatnagar
Journal:  Indian J Palliat Care       Date:  2017 Oct-Dec

5.  "Adjunctive Effects of a Short Session of Music on Pain, Low-mood and Anxiety Modulation among Cancer Patients" - A Randomized Crossover Clinical Trial.

Authors:  Gunasekara Vidana Mestrige Chamath Fernando; Lagath Udara Wanigabadu; Buddhika Vidanagama; Terancy Shyamale Perera Samaranayaka; Jeewandara Mudiyanselage Kamal Chandima Jeewandara
Journal:  Indian J Palliat Care       Date:  2019 Jul-Sep

6.  Experiences of health after dietary changes in endometriosis: a qualitative interview study.

Authors:  Jenny Vennberg Karlsson; Harshida Patel; Asa Premberg
Journal:  BMJ Open       Date:  2020-02-25       Impact factor: 2.692

Review 7.  Opioid free onco-anesthesia: Is it time to convict opioids? A systematic review of literature.

Authors:  Raghu S Thota; Seshadri Ramkiran; Rakesh Garg; Jyotsna Goswami; Vaibhavi Baxi; Mary Thomas
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2019 Oct-Dec

Review 8.  The complementary and alternative medicine for endometriosis: a review of utilization and mechanism.

Authors:  Sai Kong; Yue-Hui Zhang; Chen-Fang Liu; Ilene Tsui; Ying Guo; Bei-Bei Ai; Feng-Juan Han
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-19       Impact factor: 2.629

Review 9.  Chinese Herbal Medicine for Symptom Management in Cancer Palliative Care: Systematic Review And Meta-analysis.

Authors:  Vincent C H Chung; Xinyin Wu; Ping Lu; Edwin P Hui; Yan Zhang; Anthony L Zhang; Alexander Y L Lau; Junkai Zhao; Min Fan; Eric T C Ziea; Bacon F L Ng; Samuel Y S Wong; Justin C Y Wu
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

10.  Intradermal Acupuncture Along with Analgesics for Pain Control in Advanced Cancer Cases: A Pilot, Randomized, Patient-Assessor-Blinded, Controlled Trial.

Authors:  Kyungsuk Kim; Sanghun Lee
Journal:  Integr Cancer Ther       Date:  2018-07-16       Impact factor: 3.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.